The drug targets a specific mutation that applies to only 2% of ALS patients. A new drug may slow progression of -- and even reverse -- symptoms of a rare form of amyotrophic lateral sclerosis, or ALS ...
A new drug may slow progression of — and even reverse —  symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds.